Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Ipca-Ibuprofen |
| Active Ingredient: | Ibuprofen 200mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Paracetamol Soft Gel Caps Extra |
| Active Ingredients: | Caffeine 65mg Paracetamol 500mg |
| Dosage Form: | Soft gelatin capsule |
| New Zealand Sponsor: | AFT Pharmaceuticals Limited |
| Manufacturer: | XL Laboratories Pvt. Limited, Neemrana, India |
| Product: | Verorab |
| Active Ingredient: | Rabies vaccine, Wistar PM/WI 38-1503-3M 3.25IU |
| Dosage Form: | Powder for injection with diluent |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | Sanofi Pasteur SA, Marcy L’Etoile, France |
Dated this 11th day of March 2024.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).